Compare TX & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TX | RVTY |
|---|---|---|
| Founded | 1961 | 1937 |
| Country | Luxembourg | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 11.6B |
| IPO Year | 2006 | 1994 |
| Metric | TX | RVTY |
|---|---|---|
| Price | $46.30 | $100.00 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 16 |
| Target Price | $37.70 | ★ $109.67 |
| AVG Volume (30 Days) | 557.6K | ★ 1.3M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | ★ 6.31% | 0.34% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.36 |
| Revenue | N/A | ★ $3,311,822,000.00 |
| Revenue This Year | $9.60 | $6.37 |
| Revenue Next Year | $6.66 | $5.10 |
| P/E Ratio | ★ $20.15 | $278.79 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $28.77 | $81.22 |
| 52 Week High | $51.73 | $118.30 |
| Indicator | TX | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 46.06 | 52.53 |
| Support Level | $41.73 | $94.93 |
| Resistance Level | $49.69 | $103.73 |
| Average True Range (ATR) | 1.72 | 3.68 |
| MACD | -0.38 | -0.48 |
| Stochastic Oscillator | 2.16 | 33.64 |
Ternium SA is a flat steel producer operating in Mexico, Brazil, Argentina, Colombia, the southern United States, and Central America. It produces finished and semi-finished steel products and iron ore, which are sold either directly to steel manufacturers and steel processors or end-users. The company operates in two segments: Steel and Mining. In its Steel segment, the company produces slabs, billets & round bars, hot-rolled coils & sheets, bars & stirrups, wire rods, steel pipes, and other products. The Mining segment sells iron ore as concentrates (fines) and pellets. The vast majority of its revenue comes from the Steel segment and geographically from Mexico.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.